Intelligent Bio Solutions Inc. (INBS) stock
INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3057% below fair value
$1.56+0.06 (+4.00%)
Close on Nov 17, 2026Market cap $4.72MP/E –Yield –
Intelligent Bio Solutions cash
Cash and short-term investments held at the end of each period.
Intelligent Bio Solutions's cash was $3.99M at Jun 30, 2026. For fiscal 2026 it was $3.99M, up 291.4% from the year before. The highest annual figure on record is $12.57M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $3.99M | +291.4% |
| FY2025 | Jun 30, 2025 | $1.02M | -83.8% |
| FY2024 | Jun 30, 2024 | $6.30M | +310.1% |
| FY2023 | Jun 30, 2023 | $1.54M | -81.3% |
| FY2022 | Jun 30, 2022 | $8.24M | -34.5% |
| FY2021 | Jun 30, 2021 | $12.57M | +2842.8% |
| FY2020 | Jun 30, 2020 | $427.27K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $3.99M | +291.4% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $6.86M | +144.5% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $740.37K | -67.0% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $1.66M | -58.4% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $1.02M | -83.8% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $2.81M | -70.1% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $2.24M | +100.4% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $3.99M | +2040.2% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $6.30M | +310.1% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $9.40M | +312.1% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $1.12M | -61.6% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $186.40K | -96.8% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $1.54M | -81.3% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $2.28M | -78.8% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $2.91M | -74.0% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $5.74M | -54.5% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $8.24M | -34.5% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $10.76M | -24.6% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $11.19M | -43.7% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $12.61M | +2850.9% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $12.57M | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $14.26M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $19.88M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $427.27K | – |
See a number that looks wrong?